about
The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitorsComparing women pharmacy consumers' experiences with weight loss treatment in Victoria and Nottingham: a cross-sectional study.Medicines use reviews: a potential resource or lost opportunity for general practice?Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey.Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements.What proportion of prescription items dispensed in community pharmacies are eligible for the New Medicine Service?The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmacies.A method to determine if consenters to population surveys are representative of the target study population.Community pharmacists' attitudes towards medicines use reviews and factors affecting the numbers performed.A qualitative study exploring the impact and consequence of the medicines use review service on pharmacy support-staff.Understanding the patient perspective of the English community pharmacy Medicines Use Review (MUR).Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.A multi-method evaluation of the Pharmacy First Minor Ailments scheme.Herbal and dietary supplement use in Bangkok: a survey.An investigation of body image concern and the effects of sociocultural factors among U.K. first year university students.Effectiveness of a community pharmacy weight management programme.Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.Association of herbal and dietary supplements with progression and complications of chronic kidney disease: a prospective cohort study.Information sources used by parents buying non-prescription medicines in pharmacies for preschool children.Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.Epidemiology of headache in an English districtSelf reported clinical pharmacist interventions under-estimate their input to patient careA survey of the provision of clinical pharmacy services in relation to existing published standardsWhy do older people report fewer headaches?One-year follow-up of headache in an adult general populationUse of community pharmacies: a population-based survey
P50
Q26866168-2E21D256-E0F6-488B-9FB7-0935BE65F9A5Q33890639-6E3BCD3C-7908-4ED1-B14D-11F7787D4BDBQ34707697-B87F81D3-ECF5-4160-93FB-875B5AC43237Q34788437-A127AEAB-C1F9-4745-93B9-FFE9B8D70D2CQ34969344-13F3EE77-88AE-492D-9D58-05A22C732B00Q35114087-1D129C14-2FAB-4B8A-B9B4-CE6F30C0A9C0Q35134872-5F4BFF1C-6CCA-4853-8E16-EA7EDCDBC691Q36073387-BCC6BAA0-1879-426A-8626-B5EB7082A80EQ37089802-3D528D0A-D262-4016-AB26-47D4C691D507Q37233400-2EDCF07E-3CD2-404C-8240-8053CFF74838Q38090743-47A74D14-C556-48BF-9DE2-A9ECD6F8DEA8Q38464265-1828DBFE-FE8F-4079-BAB6-E0AC72C2E954Q44400246-F678FDD9-FCE1-415B-A3BE-DAA5A8C5207CQ46920947-54CD11F4-8F8B-4C5B-9ABC-C0A09FB8976AQ47223563-AE762E06-569B-4B98-B76D-707C3D9D45C2Q47449065-07ACE47E-041A-41D0-A43C-C1A0EC2A1E30Q50194686-661D8BEE-9B00-4304-9990-D7FF02A5A45BQ50909304-E6BBBD08-532E-4D6D-9022-C0A0559B5C50Q51016063-FD646D42-23B2-45E3-BF6D-C7B7427058FBQ53332804-F335D407-26E6-4718-BE28-3CBECEDCDECDQ73042077-EA6AFF6B-792A-4A14-8469-4F7760866194Q74038371-F7FAEB71-5CA3-43A6-85A7-D7F060FCE584Q81051141-B806458E-B640-46E6-88B5-D6C168EAC1C2Q81085392-D8D5DF76-6AA9-4E0E-8083-35CBB4C250A9Q81660734-0863DE5B-DBCB-43CC-B216-A3AB78C3F481Q81712822-38897FE4-A8B3-4320-A333-5F03B725A909
P50
description
researcher ORCID ID = 0000-0002-5341-5619
@en
wetenschapper
@nl
name
Helen F Boardman
@ast
Helen F Boardman
@en
Helen F Boardman
@es
Helen F Boardman
@nl
type
label
Helen F Boardman
@ast
Helen F Boardman
@en
Helen F Boardman
@es
Helen F Boardman
@nl
prefLabel
Helen F Boardman
@ast
Helen F Boardman
@en
Helen F Boardman
@es
Helen F Boardman
@nl
P106
P1153
7003532370
P31
P496
0000-0002-5341-5619